Valvular heart disease in treatment of Parkinson's disease with ergot derivative dopamine agonists

被引：0
|
作者：
Kim, JY
Lee, WY
Chung, EJ
Park, SW
机构：
来源：
MOVEMENT DISORDERS | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [41] Assesment of valvulopathy in Parkinson's disease patients on ergot derived dopamine receptor agonists
    Candan, F.
    Cakmak, O. Oztop
    Isik, N.
    Ciftci, H.
    Canturk, I. Aydin
    Basbugu, C.
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 : 166 - 166
  • [42] Pathological gambling (PG) in Parkinson Disease (PD) during ergot and non-ergot dopamine agonists treatment
    Antonini, A.
    Siri, C.
    De Gaspari, D.
    Canesi, M.
    Meucci, N.
    Rauhe, C.
    Schiavella, M.
    Isaias, I. U.
    Cilia, R.
    Pezzoli, G.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S657 - S657
  • [43] Valvular heart disease and B-type Natriuretic Peptide (BNP) in Parkinson's disease treated with ergot doparnine agonists: An echocardiographic study
    Aoki, Y.
    Takamizawa, I.
    Oya, Y.
    Ogawa, M.
    Murata, M.
    Kuno, S.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S548 - S549
  • [44] Dopamine agonists for Parkinson's disease
    Sharma, J
    MacMahon, D
    Stewart, D
    [J]. LANCET, 2003, 361 (9351): : 84 - 84
  • [45] Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography study
    Junghanns, Susann
    Fuhrmann, Joerg T.
    Simonis, Gregor
    Oelwein, Christian
    Koch, Rainer
    Strasser, Ruth H.
    Reichmann, Heinz
    Storch, Alexander
    [J]. MOVEMENT DISORDERS, 2007, 22 (02) : 234 - 238
  • [46] Dopamine agonists in Parkinson's disease
    Tintner, R
    Jankovic, J
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (11) : 1803 - 1820
  • [47] Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
    Perez-Lloret, Santiago
    Rey, Maria Veronica
    Crispo, James
    Krewski, Daniel
    Lapeyre-Mestre, Marise
    Montastruc, Jean-Louis
    Rascol, Olivier
    [J]. EXPERT OPINION ON DRUG SAFETY, 2014, 13 (03) : 351 - 360
  • [48] Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease
    Crispo, James A. G.
    Farhat, Nawal
    Fortin, Yannick
    Perez-Lloret, Santiago
    Sikora, Lindsey
    Morgan, Rebecca L.
    Habash, Mara
    Gogna, Priyanka
    Kelly, Shannon E.
    Elliott, Jesse
    Kohen, Dafna E.
    Bjerre, Lise M.
    Mattison, Donald R.
    Hessian, Renee C.
    Willis, Allison W.
    Krewski, Daniel
    [J]. BRAIN SCIENCES, 2024, 14 (08)
  • [49] Dopamine receptor agonists in the treatment of advanced Parkinson's disease
    Stocchi, Fabrizio
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S54 - S57
  • [50] Dopamine agonists treatment in Parkinson's disease:: Experience with pergolide
    Ruzicka, E
    Jech, R
    Roth, J
    Michalcíková, B
    Mecír, P
    Volfová, M
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2000, 63 (05) : 283 - 290
12345